^
BIOMARKER:
JAK2 underexpression
i
Other names: JTK10, THCYT3, JAK2, Janus Kinase 2, Tyrosine-Protein Kinase JAK2, JAK-2
Entrez ID:
Related biomarkers:
›
JAK2 underexpression
|
Cutaneous Melanoma
|
JAK2 underexpression
|
Cutaneous Melanoma
|
TL-1-85 Sensitive: C3 – Early Trials
|
TL-1-85 Sensitive: C3 – Early Trials
|
JAK2 underexpression
|
Cutaneous Melanoma
|
JAK2 underexpression
|
Cutaneous Melanoma
|
QL-VIII-58 Sensitive: C3 – Early Trials
|
QL-VIII-58 Sensitive: C3 – Early Trials
|
JAK2 underexpression
|
Cutaneous Melanoma
|
JAK2 underexpression
|
Cutaneous Melanoma
|
ruxolitinib Resistant: C3 – Early Trials
|
ruxolitinib Resistant: C3 – Early Trials
|
JAK2 underexpression
|
Cutaneous Melanoma
|
JAK2 underexpression
|
Cutaneous Melanoma
|
fedratinib Resistant: C3 – Early Trials
|
fedratinib Resistant: C3 – Early Trials
|
JAK2 underexpression
|
Cutaneous Melanoma
|
JAK2 underexpression
|
Cutaneous Melanoma
|
sunitinib Resistant: C3 – Early Trials
|
sunitinib Resistant: C3 – Early Trials
|
